like to see, look, if mcdonald's can come out with killer products, apple -- are theybothtechnologycompanies?is that where we are right now? >> apple has come out with incredible products. amazing products that have changed the world. >> that was the old days and the yankees used to be -- >> the ipad is only three years old, man. come on, give them a break. >> no. the market won't give them a break. i like the product, but who am i? >> that's complicated. >> it was not a rhetorical -- you know, we're not trying to figure out exactly whoi am. >> oh, okay. >> what we're trying to figure out how do they make i tunes better and how you want them to come out and say samsung, you're history because we have this. instead of samsung having, what? eight pages. >> you're not going get that in an earnings report. >> someone innovates and someone else comes in with a pretty good or good enough and that's why people are talking about the lower end and the medium end. >> there are some people who their samsung phones have technology whether it's the ability to change language quickly and a numb

. what i'm calling meat and potatoes rally. look at this, materials, consumerstams,technologyfinancialsand discretionary are among the gainers today. i want to highlight technology very quickly, because we're expecting earnings from intel and yahoo! after the close tonight. intel is trading higher at this hour, while yahoo! is down half a percent right now. >> fedex, of course, on the eve of its 40th anniversary, in less than an hour, employees will be ringing the closing bell. the stock viewed as a barometer of economic conditions has been on a slide after the company cut its outlook for the year. up to that point, the stock had been riding this market rally. we want to drill down into the outlook, how the company is dealing with the global economy. joining us is fred smith. fred, it's always nice to have you on the program. we appreciate your time. >> thank you, maria. >> what can you tell us about the rest of the year at fedex and the industry? i think when you first came out with the news, the last time we spoke, about the global economy, it shook the market. it certainl

. supportingscience,technology, andimproved economic performance and financial literacy in the 21st century. >> and with the ongoing support of these institutions and foundations. and... >> this program was made possible by the corporation for public broadcasting. and by contributions to your pbs station from viewers like you. thank you. >> ifill: 27 runners and thousands more spectators had turned out for the boston marathon today when terror erupted. two bombs exploded, and authorities said two people were killed and more than 50 others were wounded. (sirens). within minutes of the blast, wheelchairs and stretchers were ferrying victims up and down boylston street, the home stretch of the oldest marathon race in the world. amid the chaos competitors, race volunteers and spectators ran from the scene in shock. >> i went over there. there were body parts. people were blown apart. they're dead. where the wind owe is, the windows were all blown out. >> ifill: the attack came about three hours after the winners had crossed the finish line. a loud explosion on the north side of the street went

? >> i think that that is true. you're looking at what is going to enablethetechnologytoget to the most patients the quickest and the most reliably. frankly myriad has done a great job of doing that because there are more people who have gotten this test than i think would have gotten it otherwise more consistently and more reliably than if it had been scattered among hundreds of thousands of individual research labs. >> brown: ellen, address that specifically. that claim has been put out there that scholarly work has hardly been stopped. there's been plenty of research done. i mean studies of the research done on this. >> i think those of us in the know will tell you that this has had a chilling effect on research and not as much research has been able to be done. one company has had a monopoly on this testing. for companies and laboratories that wanted to find better ways to look for mutations, faster ways, less expensive ways, they've been stopped. yes, myriad has done a great job of marketing this test to a lot of people because they have a huge financial incentive. but